Discussions

Public formularies are starting to cover biosimilar insulins instead of their reference biologic drugs and it is predicted that this will save millions of dollars annually.

Take our weekly doctor poll. See what your colleagues say.

As I prepared my children’s orange shirts earlier this week, I couldn’t help but reflect on what a different world this conversation now lives in.

A colleague of mine was worried that the curriculum teaches about sexual orientation, because “he doesn’t believe in that.”

Dr. Howard Goldstein challenged doctors in his Virtual Retirement Lounge group to come up with keynote addresses to the class of 2023.

In looking at historic cases and my own, I question where serendipity fits into all of it.

Hydrochlorothiazide remains a viable option for older patients with hypertension, as it is associated with a lower risk of hypokalemia vs. chlorthalidone and is available in more generic single-pill combinations.

I know I’m not alone in feeling that our world has gotten a little bit meaner in recent years.